Inflammatory low back pain for more than three months, although with a tendency towards marginal significance (p-value 0.053), increased the risk of treatment discontinuation by 40.0% ( Table 3 ).
← all excerpts
Evaluation of the performance of biological drugs in the treatment of ankylosing spondylitis: cohort study, Minas Gerais, 2018-2023.
1
—
—